usa.chinadaily.com.cn
CIIE 2023: Healthcare Innovations and Collaborations
The 7th China International Import Expo (CIIE) saw participation from major healthcare companies showcasing innovative technologies and seeking collaborations.
English
China
HealthChinaHealthcareInnovationCollaborationCiie
LundbeckOrganonHaier GroupIncaierCapital Medical University
Jens HoeyerZafer UnluerDong Yilang
- What was Organon's main focus at this year's CIIE?
- Organon, a US-based pharmaceutical company, focused on women's reproductive health innovations at CIIE, aiming to address the needs of Chinese families and collaborate with local partners.
- What was Lundbeck's objective in participating in the CIIE?
- Lundbeck, a Danish neuroscience pharmaceutical company, participated in CIIE for the first time, showcasing its treatments for brain diseases and aiming to introduce global innovations to China.
- What significant innovations did Incaier showcase at the expo?
- Incaier, Haier Group's healthcare arm, showcased over 40 innovative products and solutions at CIIE, including a prototype intravascular targeted temperature management system for stroke treatment.
- What was the overall impact and significance of the seventh CIIE?
- CIIE's seventh edition attracted numerous leading pharmaceutical and medical device companies, launching many innovative health technologies and services in China.
- What is the main purpose of the China International Import Expo (CIIE) for healthcare companies?
- The China International Import Expo (CIIE) provides a platform for healthcare companies to showcase achievements and collaborate, expanding market opportunities.